2cureX AB (publ) (FRA:2QE)
Germany · Delayed Price · Currency is EUR 0.1255
+0.0020 (1.62%)
At close: Nov 26, 2025
2cureX AB Company Description
2cureX AB (publ) operates as a medtech company in Europe.
The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment.
It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers.
In addition, the company offers research and consulting services. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
2cureX AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 14 |
| CEO | Nathaniel Hutley |
Contact Details
Address: Fruebjergvej 3 Copenhagen, 2100 Denmark | |
| Phone | 45 22 11 53 99 |
| Website | 2curex.com |
Stock Details
| Ticker Symbol | 2QE |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Nathaniel Hutley | Chief Executive Officer |
| Kenneth Johansen | Chief Financial Officer |